Home-based testing (n=9258) | Clinic-based testing (n=19193) | P value | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | |||||||||||||||
16–24 | >25 | 6033 (65%) | 3225 (35%) | 9654 (50%) | 9539 (50%) | <0.001 | |||||||||
Gender | |||||||||||||||
Female | Male | Transgender | 5986 (65%) | 3258 (35%) | 14 (0%) | 10861 (57%) | 8306 (43%) | 26 (0%) | <0.001 | ||||||
Ethnicity | |||||||||||||||
White | Black/British Black | Asian/British Asian | Other: | Not specified: | 6648 (72%) | 892 (10%) | 558 (6%) | 920 (10%) | 240 (3%) | 7996(42%) | 4026 (21%) | 2167(11%) | 2160 (11%) | 2844 (15%) | <0.001 |
Asymptomatic | 7408/9258 (80%) | 9729/19193 (51%) | <0.001 | ||||||||||||
Return rate | 4476 (48%) | – | |||||||||||||
Prevalence rates | 382/4476 (9%) | 2141/19193 (11%) | <0.001 | ||||||||||||
Treatment rate | 174/382 (46%) | 1663/2141 (78%) | <0.001 |